Loteprednol

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z8CBU6KR16. European Medicines Agency schedules Loteprednol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08599MIG. Loteprednol generally arises in the molecular formula C21H27CLO5. The term LOTEPREDNOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31.) LOTEPREDNOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule loteprednol under HS 29372900 and SITC 54153. As of Q4 2014, LOTEPREDNOL remains the US FDA Preferred Term for this commodity. Loteprednol bears US NLM identifiers UMLS ID C0772364 and NCI Concept Code C72818. SMILES: CC12CC(C3C(C1CCC2(C(=O)OCCL)O)CCC4=CC(=O)C=CC34C)O.